ClinicalTrials.gov
ClinicalTrials.gov Menu

Expression of Optic Atrophy Type 1 (OPA1) Protein in Lung Adenocarcinoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01249053
Recruitment Status : Unknown
Verified November 2010 by China Medical University Hospital.
Recruitment status was:  Recruiting
First Posted : November 29, 2010
Last Update Posted : November 29, 2010
Sponsor:
Information provided by:
China Medical University Hospital

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Unknown
  Primary Completion Date : No date given
  Study Completion Date : No date given